Docosahexaenoic acid intake and health in adults and older adults: a narrative review of disparities by country income level
Abstract
Docosahexaenoic acid (DHA) is a long-chain omega-3 polyunsaturated fatty acid essential for maintaining optimal brain and cardiometabolic health across adulthood and aging. Despite its biological relevance, global evidence indicates substantial variability in DHA intake and status, largely influenced by dietary patterns, food availability, and socioeconomic conditions. This narrative review synthesized observational and interventional studies published between 2014 and 2026 that evaluated DHA intake or biomarkers in adults and older adults, emphasizing disparities according to country income level. Studies were categorized following the World Bank Gross National Income (GNI) classification and analyzed to describe intake patterns, biochemical concentrations, and their reported health associations. Important inequities were observed between countries. Populations in high-income countries (HICs) generally reported higher DHA intake and tissue concentrations, mainly due to regular fish consumption and greater access to supplementation, while evidence from middle-income countries (MICs) was scarce, heterogeneous, and based on small non-representative samples. In HICs, even moderate fish intake significantly improved DHA status, whereas in MICs, mean intakes frequently fell below 200 mg/day, a threshold commonly associated with cardiometabolic and neurocognitive benefits. Higher DHA levels were consistently linked to more favorable lipid profiles, lower triglyceride…
Read the paper
Related studies
- Promising Sources of Plant-Derived Polyunsaturated Fatty Acids: A Narrative Review
- Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: Systematic review and meta-analysis of randomized controlled trials
- Effect of omega-3 fatty acids on cognition: an updated systematic review of randomized clinical trials
- The role of omega-3 polyunsaturated fatty acid supplementation in the management of type 2 diabetes mellitus: A narrative review
- Paucity of evidence for a relationship between long-chain omega-3 fatty acid intake and chronic obstructive pulmonary disease: a systematic review
- Omega-3 fatty acid nanocarriers: Characterization and potential applications
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.